DrugsControl Media Services

News Detail

SC junks plea on efficacy of Remdesivir, Favipiravir for treatment of Covid (12-04-2023)

New Delhi, 11 April 2023: The Supreme Court on Monday dismissed a plea alleging use of drugs Remdesivir and Favipiravir, without approval, for treatment of Covid-19 and also seeking CBI probe against ten Indian pharmaceutical firms for selling these medicines allegedly in the abs......
View Details

Source : IANS
Supreme Court Remdesivir and Favipiravir without approval treatment of Covid-19 Indian pharmaceutical firms valid licenses

Related News